Oxford ECMC aims to apply basic scientific discoveries in cancer biology to the development of novel cancer therapies and prognostic/diagnostic biomarkers to help individualise patient care. The Centre has expertise in immunology, DNA repair, angiogenesis and molecular pathology and has facilities for conducting imaging, proteomics, microarray and radioisotope studies.
Clinical Focus Area
- Phase 0 trials
Scientific Focus Area
- DNA damage processing
Disease Focus Area
|Pancreatic||Prostate||Relevant to all types of cancer|
For further information on the goals and objectives of Oxford ECMC go to:
Oxford ECMC principal investigators and staff have a diverse range of skills and expertise.
Oxford ECMC has access to a range of research facilities that are utilised in studies.